Status:
COMPLETED
Four-Week SkinSiteStudy in Type 1 Diabetes
Lead Sponsor:
Steno Diabetes Center Copenhagen
Conditions:
Type 1 Diabetes
Eligibility:
All Genders
6-17 years
Phase:
NA
Brief Summary
Using insulin pumps and sensors to monitor blood glucose has become standard of care for children with diabetes. The continous infusion of insulin in the subcutaneous tissue leads to increased risk of...
Detailed Description
An increasing proportion of patients with diabetes mellitus type 1 (T1D) is using diabetes devices in order to achieve better glycemic control, improved quality of life and more flexible lifestyle (1-...
Eligibility Criteria
Inclusion
- type 1 diabetes,
- using CE marked automatic insulin delivery system,
- using insulin pump for at least 6 months
Exclusion
- Do not use bolusguide (entering carbs),
- not trained in carbohydrate counting,
- unable to understand and read Danish
Key Trial Info
Start Date :
December 8 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 25 2024
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT06177054
Start Date
December 8 2023
End Date
June 25 2024
Last Update
July 31 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Steno Diabetes Center Copenhagen
Herlev, Capital, Denmark, 2730